Abbott is recalling the Ellipse Implantable Cardioverter Defibrillators (ICDs) because electrical failures have been identified and determined to be due to a faulty manufacturing process, causing...
Implantable Cardioverter Defibrillator (ICD)
This channel includes news and new technology innovations for implantable cardioverter defibrillators (ICD) used to treat tachycardia arrhythmias and heart failure. This includes cardiac resynchronization therapy defibrillators (CRT-D).
-
-
MRI-compatible ICDs is a growing trend in the market. This example is Biotronik's Lumas 740 ICD.
This is a brief overview of updates on implantable cardioverter defibrillators (ICD), ...
-
May 15, 2019 — A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1] The new scoring system was presented as a follow up to that study during a late-...
-
May 15, 2019 - Three new studies show that patients who are medically indicated for implantable heart devices, including...
News | Implantable Cardioverter Defibrillator (ICD) | September 18, 2019
September 18, 2019 — Early use of an...
News | Leads Implantable Devices | August 05, 2019
August 5, 2019 — Abbott is recalling the Ellipse...
News | EP Lab | July 31, 2019
July 31, 2019 — The chances of patients experiencing complications after having a cardiac device implanted vary...
News | Sudden Cardiac Arrest | July 02, 2019
For patients at risk for sudden cardiac arrest (SCA) who are being evaluated for a permanent implantable...
A physician explaining an implantable cardioverter defibrillator (ICD) to a patient. Image courtesy of Biotronik.
Feature | Implantable Cardioverter Defibrillator (ICD) | May 24, 2019 | Dave Fornell, Editor
This is a brief overview of updates on...
![A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1] The new scoring system was presented as a follow up to that study during a late-breaking session at Heart Rhythm 2019, the Heart Rhythm Society's 40th Annual Scientific Sessions.](https://sgcweb-west.s3.us-west-1.wasabisys.com/dicardiology/s3fs-public/styles/content_feed_medium/public/PADIT_Infection_Risk_score.jpg?itok=sF0KB0mC)
Figure 1: The PADIT infection risk score ranging from 0 to 14 points classified patients into three risk groups, low (0-4), intermediate (5-6) and high (≥7). The risk groups had rates of hospitalization for infection of 0.51%, 1.42% and 3.41%, respectively
News | EP Lab | May 15, 2019
May 15, 2019 — A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1]...
News | EP Lab | May 15, 2019
May 15, 2019 - Three new studies show that patients who are medically indicated for implantable heart devices,...
A new study shows travelers with common cardiac devices can pass through airport body scanners without restrictions or precautions.
News | EP Lab | May 14, 2019
May 14, 2019 – Results from new research show that passengers with cardiac implantable electronic devices (CIEDs),...
News | Implantable Cardioverter Defibrillator (ICD) | May 13, 2019
May 13, 2019 — Boston Scientific announced acute results from the UNTOUCHED study evaluating safety and efficacy of...
News | EP Lab | May 13, 2019
May 13, 2019 – Results from a new survey are the first to report a large discrepancy in patient’s knowledge of their...
Medtronic's investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system.
News | May 13, 2019
May 13, 2019 – A first-in-human pilot study of Medtronic's investigational Extravascular Implantable Cardioverter...
News | Cardiac Resynchronization Therapy Devices (CRT) | April 29, 2019
April 29, 2019 — Biotronik announced the full commercial launch of the Acticor device family, including Acticor DX...
News | Cardiac Resynchronization Therapy Devices (CRT) | April 18, 2019
April 18, 2019 – Biotronik announced the European market release of what it calls the world’s smallest...
Concerto CRT-D and Virtuoso ICD implantable cardiac devices are among several Medtronic electrophysiology devices included in a safety alert because of their lack of cybersecurity measures to avoid hacking, according to the FDA.
Feature | EP Lab | March 22, 2019
March 22, 2019 — The U.S. Food and Drug Administration (FDA) issued a safety communication to alert healthcare...
